Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Biochemics, Inc. v. Axis Reinsurance Company
Case Number:
1:13-cv-10691
Court:
Nature of Suit:
Judge:
Firms
-
January 06, 2015
Insurer Shakes BioChemic's Suit Over SEC Subpoena Claim
A Massachusetts federal judge on Tuesday ruled that Axis Reinsurance doesn't have a duty to defend BioChemics Inc. in U.S. Securities and Exchange Commission subpoenas and an SEC enforcement action, because its claim was made before directors and officers coverage went into effect.
-
February 18, 2014
BioChemics, D&O Insurer Battle Over SEC Subpoena Claim
Axis Reinsurance Co. and BioChemics Inc. each urged a Massachusetts federal court Friday to grant summary judgment in a directors and officers coverage dispute over U.S. Securities and Exchange Commission subpoenas and an SEC enforcement action, debating whether the underlying claims were connected to claims made before an Axis policy took effect.
-
August 09, 2013
Axis Scores Docs In D&O Coverage Fight With BioChemics
Axis Reinsurance Co. will be able to delve into BioChemics Inc.'s communications with the U.S. Securities and Exchange Commission after a Massachusetts federal judge on Wednesday cleared the way for discovery in a suit over directors and officers coverage for an SEC enforcement action.